Induction Medium for adipogenic differentiation of mesenchymal stem cells
For efficient transfection of parasites, e.g. Plasmodium berghei or Trypanosoma brucei, in Nucleofector® I/II/2b Device
Pooled 50-donor, mixed gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Flexible media system for gene therapy process development and high-titer AAV production in HEK293 cells
-
CHO Media PortfolioMaximize Your Protein Expression With Our CHO Media
-
TheraPRO® CHO Media SystemToss sheet used to promote the TheraPRO CHO Media System
-
CHO Introduction Customer Facing PresentationFor sales to use when presenting CHO to customers/prospects
-
TheraPRO® CHO Instructions for UseInstructions on how to use the TheraPRO® CHO Media System
-
4D-Nucleofector® Protocol for CHO-K1Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for CHO-K1
-
TheraPRO® CHO Media System - Instructions for useInstructions on how to use the TheraPRO® CHO Media System
-
TheraPRO® CHO Scalability Therapeutic Protein Production, SimplifiedWhitepaper focusing on the scalability of the TheraPRO® CHO expansion medium
-
CHO-K1 Transfection Protocol - 4D-Nucleofector™ DeviceInstructions of use for transfection of CHO-K1 cells with the SF Cell Line 4D-Nucleofector™ X Kit
-
BE02-056Q CHO Xtreme™ Feed CD - InstructionsBE02-056Q
-
eCHO® Basal Medium and eCHO® Feed Product InformationChemically defined serum-free CHO medium for fed-batch cell culturing